DNLRX
Price
$62.90
Change
+$0.48 (+0.77%)
Updated
Jul 3 closing price
Net Assets
473.18M
VEXMX
Price
$149.96
Change
+$1.39 (+0.94%)
Updated
Jul 3 closing price
Net Assets
107.69B
Interact to see
Advertisement

DNLRX vs VEXMX

Header iconDNLRX vs VEXMX Comparison
Open Charts DNLRX vs VEXMXBanner chart's image
BNY Mellon Active MidCap I
Price$62.90
Change+$0.48 (+0.77%)
VolumeN/A
Net Assets473.18M
Vanguard Extended Market Index Investor
Price$149.96
Change+$1.39 (+0.94%)
VolumeN/A
Net Assets107.69B
DNLRX vs VEXMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DNLRX vs. VEXMX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLRX is a Buy and VEXMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXMX has more cash in the bank: 108B vs. DNLRX (473M). VEXMX (1.01) and DNLRX (0.99) have matching dividends . DNLRX was incepted earlier than VEXMX: DNLRX (23 years) vs VEXMX (38 years). DNLRX (0.92) is less costly to investors than VEXMX (0.19). DNLRX is a more actively managed with annual turnover of: 51.78 vs. VEXMX (11.00). DNLRX has a lower initial minimum investment than VEXMX: DNLRX (1000) vs VEXMX (3000). VEXMX annual gain was more profitable for investors over the last year : 16.37 vs. DNLRX (7.36). VEXMX return over 5 years is better than : 66.68 vs. DNLRX (35.22).
DNLRXVEXMXDNLRX / VEXMX
Total Expense Ratio0.750.19395%
Annual Report Gross Expense Ratio0.920.19484%
Fund Existence23 years38 years-
Gain YTD4.8563.166153%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets473M108B0%
Annual Yield % from dividends0.991.0197%
Returns for 1 year7.3616.3745%
Returns for 3 years28.4748.2459%
Returns for 5 years35.2266.6853%
Returns for 10 years10.32120.869%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VS2.490.11
+4.78%
Versus Systems
APLS18.260.44
+2.47%
Apellis Pharmaceuticals
HSPO12.010.03
+0.25%
Horizon Space Acquisition I Corp
BCYC7.43-0.01
-0.13%
Bicycle Therapeutics plc
GRAB4.87-0.03
-0.61%
Grab Holdings Limited